Cite
HARVARD Citation
Duffy, A. et al. (n.d.). Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC). Journal for immunotherapy of cancer. p. . [Online].